Related Experiment Videos
Evaluation of the card test for diagnosis of human brucellosis
Insights
The brucellosis card test shows high sensitivity but moderate specificity for diagnosing human brucellosis. While not ideal for clinical diagnosis, it may help identify high-risk populations in serological surveys.
Area of Science:
- Immunology
- Infectious Diseases
- Diagnostic Microbiology
Background:
- Brucellosis remains a significant global public health concern.
- Accurate serological diagnostic tools are crucial for effective management and control.
- The brucellosis card test offers a rapid diagnostic option, but its clinical utility requires thorough evaluation.
Purpose of the Study:
- To evaluate the diagnostic efficacy of the brucellosis card test.
- To compare the card test's performance against established serological methods.
- To determine the card test's sensitivity and specificity in diagnosing human brucellosis.
Main Methods:
- A comparative study involving 1,701 human serum specimens.
- Evaluation of the card test against standard tube agglutination, centrifugation agglutination, 2-mercaptoethanol degradation, and 2-mercaptoethanol centrifugation agglutination tests.
- Assessment of specificity using serum from tularemia patients and cholera vaccinees.
Main Results:
- The card test demonstrated a sensitivity of 95.3% and a specificity of 84.1% compared to the standard tube agglutination test.
- The test showed reactivity to both immunoglobulin G and immunoglobulin M agglutinins.
- No cross-reactivity was observed with serum from tularemia patients or cholera vaccinees.
Conclusions:
- The brucellosis card test has limited value for the presumptive serological diagnosis of clinical brucellosis in individual patients.
- The card test may be a useful tool for serological surveys to identify populations at higher risk of brucellosis.
- Further research may explore optimizing the card test for improved diagnostic accuracy.
Abstract:
The relative efficacy of the card test in the diagnosis of human brucellosis was evaluated by comparison with four other tests: the standard tube agglutination test, centrifugation agglutination test, 2-mercaptoethanol degradation technique, and 2-mercaptoethanol centrifugation agglutination test. A total of 1,701 serum specimens from persons with various degrees of potential exposure to brucella organisms or cross-reactive antigens were used in this study. In comparison with standard tube agglutination results, the card test had a sensitivity of 95.3% and a specificity of 84.1%. The card-test antigen was nonreactive with serum specimens from tularemia patients and cholera vaccinees. Our data indicated that this test measures both immunoglobulin G and immunoglobulin M agglutinins. The value of the card test in the presumptive serological diagnosis of clinical brucellosis in humans appears to be low; however, the card test may be of value in serological surveys to delineate high-risk populations.